Prognostic Impact of Renin-Angiotensin Inhibitors in Patients with Bladder Cancer Undergoing Radical Cystectomy
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic Impact of Renin-Angiotensin Inhibitors in Patients with Bladder Cancer Undergoing Radical Cystectomy
Authors
Keywords
Vascular Endothelial Growth Factor, Overall Survival, Bladder Cancer, Positive Margin, Candesartan
Journal
ANNALS OF SURGICAL ONCOLOGY
Volume 24, Issue 3, Pages 823-831
Publisher
Springer Nature
Online
2016-10-12
DOI
10.1245/s10434-016-5534-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC grafts in mice
- (2015) Susumu Ishiguro et al. CANCER BIOLOGY & THERAPY
- Targeting the VEGF pathway in metastatic bladder cancer
- (2015) Clarisse R Mazzola et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Renin-angiotensin system blockade: Its contribution and controversy
- (2015) Akira Miyajima et al. INTERNATIONAL JOURNAL OF UROLOGY
- Renin-Angiotensin Inhibitors Decrease Recurrence after Transurethral Resection of Bladder Tumor in Patients with Nonmuscle Invasive Bladder Cancer
- (2015) Michael L. Blute et al. JOURNAL OF UROLOGY
- Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities
- (2014) Michele Cavalera et al. Translational Research
- A Phase II Safety and Efficacy Study of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Patients With Metastatic Urothelial Cancer
- (2013) Roberto Pili et al. Clinical Genitourinary Cancer
- EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines
- (2013) J. Alfred Witjes et al. EUROPEAN UROLOGY
- Expression and role of the angiotensin II AT2 receptor in human prostate tissue: In search of a new therapeutic option for prostate cancer
- (2013) Marie-Odile Guimond et al. PROSTATE
- Prognostic Value of Renin–Angiotensin System Blockade in Non-muscle-invasive Bladder Cancer
- (2012) Kazuyuki Yuge et al. ANNALS OF SURGICAL ONCOLOGY
- Acquired platinum resistance enhances tumour angiogenesis through angiotensin II type 1 receptor in bladder cancer
- (2011) N Tanaka et al. BRITISH JOURNAL OF CANCER
- Angiotensin II Type 1 Receptor Expression and Microvessel Density in Human Bladder Cancer
- (2011) Suguru Shirotake et al. UROLOGY
- Potential Therapeutic Targets for Cardiac Fibrosis
- (2010) Andrew Leask CIRCULATION RESEARCH
- Angiotensin II/angiotensin II type I receptor (AT1R) signaling promotes MCF-7 breast cancer cells survival via PI3-kinase/Akt pathway
- (2010) Yanbin Zhao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Cis-dichlorodiammineplatinum Upregulates Angiotensin II Type 1 Receptors through Reactive Oxygen Species Generation and Enhances VEGF Production in Bladder Cancer
- (2010) N. Tanaka et al. MOLECULAR CANCER THERAPEUTICS
- Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy
- (2009) Stefan Wilop et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The Renin-Angiotensin System Modulates Inflammatory Processes in Atherosclerosis: Evidence from Basic Research and Clinical Studies
- (2009) Fabrizio Montecucco et al. MEDIATORS OF INFLAMMATION
- Association of ACE Inhibitors and Angiotensin Receptor Blockers with Keratinocyte Cancer Prevention in the Randomized VATTC Trial
- (2008) J. B. Christian et al. JNCI-Journal of the National Cancer Institute
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search